Closed on Jul 8, 2026

DoW Breast Cancer, Transformative Breast Cancer Consortium Development Award

Defense Health Agency Contracting Activity - DHACA · Opportunity number HT942526BCRPTBCCDA

Details summarized from the official notice as of Jun 28, 2026. Always confirm eligibility, deadlines and requirements in the official notice before applying.

Independent platform. Not affiliated with or endorsed by any government agency. Data from public federal sources.

This opportunity is closed as of Jul 8, 2026. It is kept here for reference. See the related open opportunities below, or check the official listing in case the agency posts a new cycle.

Key facts

Opportunity number	HT942526BCRPTBCCDA
Agency	Defense Health Agency Contracting Activity - DHACA Department of Defense
Assistance listing (ALN, formerly CFDA)	12.420
Posted	May 4, 2026
Deadline	Jul 8, 2026
Expected number of awards	1
Estimated total program funding	$140,000
Cost sharing or matching required	No
Funding type	Cooperative agreement
Category	Science technology and other research and development
Last updated here	Jun 28, 2026

Summary from the notice

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Transformative Breast Cancer Consortium Development Award provides successful applicants the time and resources needed to bring investigators and breast cancer consumer advocates together to establish a consortium framework and conduct preliminary research in support of an application to a future, full BCRP Transformative Breast Cancer Consortium Award (pending availability of funds). All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception.

Distinctive Features:

· This is a development award and is a separate award mechanism from the full FY26 BCRP Transformative Breast Cancer Consortium Award (HT942526BCRPTBCCA). For FY26, investigators may be named as Consortium Director on an application submitted to either (but not both) of these award mechanisms.

· Breast cancer consumer advocates must be active participants in the development and execution of the FY26 BCRP TBCCDA.

Who can apply

The official notice lists these applicant types as eligible:

Unrestricted (open to any type of entity, check the notice)

Registrations you will likely need

Most applications submitted through Grants.gov need the following. Registration can take several weeks, so start early. The notice lists the exact requirements.

SAM.gov registration for your organization, which also gives you a Unique Entity ID (UEI). Registration is free.
A Login.gov account, which Grants.gov uses for sign-in.
A Grants.gov applicant registration linked to your organization's UEI.

Past awards for this program

Totals for assistance listing 12.420 from public USASpending.gov data, as of Sep 27, 2026. Past awards do not predict future funding.

Year	Listing	Awards	Total	Average
2026	12.420	3	$933,997,648	$311,332,549
2025	12.420	4	$1,008,529,528	$252,132,382
2024	12.420	5	$3,274,258,894	$654,851,779

Hear about the next cycle

Create an account to track programs like this one. Email grant alerts are included on paid plans.

Create a free account See plans

Before you apply

Read the full official notice, including the evaluation criteria.
Confirm your organization type and location are eligible.
Check your SAM.gov registration is active.
Note the exact deadline time and time zone in the notice.

DoW Breast Cancer, Transformative Breast Cancer Consortium Development Award

Key facts

Summary from the notice

Who can apply

Registrations you will likely need

Past awards for this program

Related open opportunities

DoW Military Burn, Technology/Therapeutic Development Award

DoW Military Burn, Discovery Award

DoW Military Burn, Patient-Centered Research Award

DoW Arthritis Translational Research Award

DoW Arthritis Clinical Research Award